HAINAN SHUANGCHENG PHARMAC

Hainan Shuangcheng Pharmac Faces Flat Trajectory Amid GLP‑1 Market Shift

Hainan Shuangcheng Pharmac lags in the GLP‑1 race, trading flat and below its 200‑day average, as investors eye stronger pipelines and exclusive rights for weight‑loss drugs.

HAINAN SHUANGCHENG PHARMAC
China
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Vanessa Liu

23/10/2026, 19:07

4 minutes to read

Hainan Shuangcheng Stock Update: Price, Volatility & Cybersecurity Market Pulse

Hainan Shuangcheng Pharmac trades flat at CNY 9.04 amid 3.8 bn CNY market cap, 52‑week low of 6.36, with cybersecurity policy shifts boosting sector interest.

HAINAN SHUANGCHENG PHARMAC
China
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Elliot Mercer

22/10/2026, 09:18

2 minutes to read